CAD 1.05
(3.96%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.45 Million CAD | -22.33% |
2022 | 1.87 Million CAD | 32.03% |
2021 | 1.42 Million CAD | -43.8% |
2020 | 2.52 Million CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.43 Million CAD | -1.22% |
2024 Q2 | 1.49 Million CAD | 4.12% |
2023 Q2 | 1.84 Million CAD | -36.46% |
2023 Q1 | 2.9 Million CAD | 55.13% |
2023 Q4 | 1.45 Million CAD | -13.45% |
2023 FY | 1.45 Million CAD | -22.33% |
2023 Q3 | 1.68 Million CAD | -8.96% |
2022 Q4 | 1.87 Million CAD | -1.19% |
2022 Q3 | 1.89 Million CAD | -40.66% |
2022 Q2 | 3.19 Million CAD | 484.08% |
2022 Q1 | 547.51 Thousand CAD | -61.45% |
2022 FY | 1.87 Million CAD | 32.03% |
2021 Q1 | 2.32 Million CAD | -7.87% |
2021 FY | 1.42 Million CAD | -43.8% |
2021 Q3 | 2.61 Million CAD | 60.19% |
2021 Q2 | 1.63 Million CAD | -29.91% |
2021 Q4 | 1.42 Million CAD | -45.68% |
2020 Q4 | 2.52 Million CAD | 0.0% |
2020 FY | 2.52 Million CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | 4.19 Million CAD | 65.274% |
Asep Medical Holdings Inc | 25.61 Million CAD | 94.314% |
BetterLife Pharma Inc. | 324.74 Thousand CAD | -348.439% |
BioVaxys Technology Corp. | 113.47 Thousand CAD | -1183.322% |
ChitogenX Inc. | 534 Thousand CAD | -172.713% |
Rapid Dose Therapeutics Corp. | 1.88 Million CAD | 22.75% |
Defence Therapeutics Inc. | 477.74 Thousand CAD | -204.824% |
Entheon Biomedical Corp. | 401.07 Thousand CAD | -263.094% |
Glow Lifetech Corp. | 1.91 Million CAD | 23.875% |
Lexston Life Sciences Corp. | 750.94 Thousand CAD | -93.926% |
Pharmala Biotech Holdings Inc. | 2.41 Million CAD | 39.637% |
Doseology Sciences Inc. | 1.1 Million CAD | -32.122% |
MYND Life Sciences Inc. | 797.54 Thousand CAD | -82.597% |
Nova Mentis Life Science Corp. | 31.05 Thousand CAD | -4588.779% |
PharmaTher Holdings Ltd. | 2.58 Million CAD | 43.768% |
PreveCeutical Medical Inc. | 181.51 Thousand CAD | -702.318% |
Telescope Innovations Corp. | 3.02 Million CAD | 51.835% |